← Dashboard Aug 13, 2026 08:45 AM ET

CatalystFDA/Bio

Prelude Narrows Loss In Q2 On Lower Costs; Expects Initiation Of PRT13722 Phase 1 In Q4 FY26

Q

What changed

Why it matters

Q

Sources

Related signals

PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →

© 2026 StockDuty · Disclaimer · Terms · Privacy · Support

For informational and educational purposes only. Stock Duty provides impersonal investment research and market intelligence, not personalized investment advice. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult a qualified financial professional before making investment decisions. Stock Duty and its contributors may hold positions in securities discussed.